AliveDx

Device Transactions Financing by device companies during the third quarter of 2016 totaled $3 billion, doubling Q2's $1.5 billion. As in the past two quarters, debt offerings continue to make up the h

IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Immunotec Global PLC Immunetics Inc. Oxford Immunotec Global PLC is paying $6mm in cash to acquire Immunetics Inc. (immunoassays for infectio

IN VITRO DIAGNOSTICS Financings Quotient Ltd. Quotient Ltd. netted $45.4mm through a public sale of 8mm ordinary shares (including the overallotment) at $6. Funds will support ongoing scale-up and

Device Transactions Device companies aggregated $2.4 billion in financing for the fourth quarter of 2016, representing an 18% decrease from Q3's $3 billion. Despite the decline, Q4 put up the second-s